Morpholino

MO1-ezh1

ID
ZDB-MRPHLNO-141118-18
Name
MO1-ezh1
Previous Names
None
Target
Sequence
5' - TGTGATTTCTACACACCTCTCCACA - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
Splice-blocking MO.
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO1-ezh1
Phenotype
Phenotype resulting from MO1-ezh1
Phenotype Fish Figures
artery tbx20 expression decreased amount, abnormal AB + MO1-ezh1 Fig. 3 with image from Soto et al., 2021
artery dll4 expression decreased amount, abnormal AB + MO1-ezh1 Fig. 3 with image from Soto et al., 2021
artery efnb2a expression decreased amount, abnormal AB + MO1-ezh1 Fig. 3 with image from Soto et al., 2021
artery dlc expression decreased amount, abnormal AB + MO1-ezh1 Fig. 3 with image from Soto et al., 2021
blood vessel endothelium gata2b expression increased amount, abnormal AB + MO1-ezh1 Fig. 2 with image from Soto et al., 2021
blood vessel endothelium ab1-efnb2 labeling spatial pattern, abnormal AB + MO1-ezh1 Fig. 3 with image from Soto et al., 2021
caudal hematopoietic tissue hematopoietic multipotent progenitor cell EGFP expression increased amount, abnormal la2Tg/la2Tg + MO1-ezh1 Fig. 1 with imageFig. 4 with image from Soto et al., 2021
dorsal aorta runx1 expression increased amount, abnormal AB + MO1-ezh1 Fig. 1 with image from Soto et al., 2021
dorsal aorta myb expression increased amount, abnormal AB + MO1-ezh1 Fig. 1 with imageFig. 2 with image from Soto et al., 2021
lymphoid progenitor cell EGFP expression increased amount, abnormal zdf8Tg/zdf8Tg + MO1-ezh1 Fig. 1 with image from Soto et al., 2021
thymus rag1 expression increased amount, abnormal AB + MO1-ezh1 Fig. 1 with image from Soto et al., 2021
vascular endothelium hematopoietic progenitor cell differentiation increased occurrence, abnormal AB + MO1-ezh1 Fig. 2 with image from Soto et al., 2021
whole organism gata2b expression increased amount, abnormal AB + MO1-ezh1 Fig. 2 with image from Soto et al., 2021
whole organism runx1 expression increased amount, abnormal AB + MO1-ezh1 Fig. 1 with image from Soto et al., 2021
whole organism ezh2 expression increased amount, abnormal AB + MO1-ezh1 Fig. 4 with image from Soto et al., 2021
Phenotype of all Fish created by or utilizing MO1-ezh1
Phenotype Fish Conditions Figures
caudal hematopoietic tissue hematopoietic multipotent progenitor cell EGFP expression increased amount, abnormal la2Tg/la2Tg + MO1-ezh1 standard conditions Fig. 1 with imageFig. 4 with image from Soto et al., 2021
caudal hematopoietic tissue hematopoietic multipotent progenitor cell EGFP expression decreased amount, abnormal la2Tg/la2Tg + MO1-ezh1 chemical treatment by environment: EC 2.1.1.43 (enhancer of zeste homolog 2) inhibitor Fig. 4 with image from Soto et al., 2021
lymphoid progenitor cell EGFP expression increased amount, abnormal zdf8Tg/zdf8Tg + MO1-ezh1 standard conditions Fig. 1 with image from Soto et al., 2021
dorsal aorta myb expression increased amount, abnormal AB + MO1-ezh1 standard conditions Fig. 1 with imageFig. 2 with image from Soto et al., 2021
thymus rag1 expression increased amount, abnormal AB + MO1-ezh1 standard conditions Fig. 1 with image from Soto et al., 2021
artery dll4 expression decreased amount, abnormal AB + MO1-ezh1 standard conditions Fig. 3 with image from Soto et al., 2021
artery dlc expression decreased amount, abnormal AB + MO1-ezh1 standard conditions Fig. 3 with image from Soto et al., 2021
whole organism ezh2 expression increased amount, abnormal AB + MO1-ezh1 standard conditions Fig. 4 with image from Soto et al., 2021
blood vessel endothelium gata2b expression increased amount, abnormal AB + MO1-ezh1 standard conditions Fig. 2 with image from Soto et al., 2021
dorsal aorta runx1 expression increased amount, abnormal AB + MO1-ezh1 standard conditions Fig. 1 with image from Soto et al., 2021
artery efnb2a expression decreased amount, abnormal AB + MO1-ezh1 standard conditions Fig. 3 with image from Soto et al., 2021
artery tbx20 expression decreased amount, abnormal AB + MO1-ezh1 standard conditions Fig. 3 with image from Soto et al., 2021
whole organism runx1 expression increased amount, abnormal AB + MO1-ezh1 standard conditions Fig. 1 with image from Soto et al., 2021
vascular endothelium hematopoietic progenitor cell differentiation increased occurrence, abnormal AB + MO1-ezh1 standard conditions Fig. 2 with image from Soto et al., 2021
whole organism gata2b expression increased amount, abnormal AB + MO1-ezh1 standard conditions Fig. 2 with image from Soto et al., 2021
blood vessel endothelium ab1-efnb2 labeling spatial pattern, abnormal AB + MO1-ezh1 standard conditions Fig. 3 with image from Soto et al., 2021
blood vessel endothelium mCherry expression increased amount, abnormal s916Tg/s916Tg; zf255Tg/zf255Tg + MO1-ezh1 standard conditions Fig. 2 with image from Soto et al., 2021
blood vessel endothelium EGFP expression increased amount, abnormal s916Tg/s916Tg; zf255Tg/zf255Tg + MO1-ezh1 standard conditions Fig. 2 with image from Soto et al., 2021
blood vessel endothelial cell fate specification increased frequency, abnormal s916Tg/s916Tg; zf255Tg/zf255Tg + MO1-ezh1 standard conditions Fig. 2 with image from Soto et al., 2021
dorsal aorta hematopoietic multipotent progenitor cell mCherry expression increased amount, abnormal s916Tg/s916Tg; zf169Tg/zf169Tg + MO1-ezh1 standard conditions Fig. 3 with image from Soto et al., 2021
dorsal aorta hematopoietic multipotent progenitor cell GFP expression increased amount, abnormal s916Tg/s916Tg; zf169Tg/zf169Tg + MO1-ezh1 standard conditions Fig. 3 with image from Soto et al., 2021
Citations